Overview
flowchart TD
entities_microtubules["Expand Microtubules content"]
style entities_microtubules fill:#4fc3f7,stroke:#333,color:#000
entities_microtubule_0["Structure and Composition"]
entities_microtubules -->|"includes"| entities_microtubule_0
style entities_microtubule_0 fill:#81c784,stroke:#333,color:#000
entities_microtubule_1["Assembly and Architecture"]
entities_microtubules -->|"includes"| entities_microtubule_1
style entities_microtubule_1 fill:#ef5350,stroke:#333,color:#000
entities_microtubule_2["Tubulin Isotypes"]
entities_microtubules -->|"includes"| entities_microtubule_2
style entities_microtubule_2 fill:#ffd54f,stroke:#333,color:#000
entities_microtubule_3["Dynamic Instability"]
entities_microtubules -->|"includes"| entities_microtubule_3
style entities_microtubule_3 fill:#ce93d8,stroke:#333,color:#000
entities_microtubule_4["Role in Axonal Transport"]
entities_microtubules -->|"includes"| entities_microtubule_4
style entities_microtubule_4 fill:#4fc3f7,stroke:#333,color:#000
entities_microtubule_5["Molecular Motors"]
entities_microtubules -->|"includes"| entities_microtubule_5
style entities_microtubule_5 fill:#81c784,stroke:#333,color:#000Expand Microtubules Content plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Microtubules are dynamic cytoskeletal polymers essential for cell structure, intracellular transport, and cell division in all eukaryotic cells[^1]. In neurons, microtubules are particularly critical for axonal and dendritic transport, synaptic function, neuronal polarity, and overall cell viability[^2]. These hollow cylindrical structures are composed of α/β-tubulin heterodimers and exhibit dynamic instability—the constant growth and shrinkage that enables rapid reorganization in response to cellular signals[^3].
Dysfunction of microtubules has emerged as a critical contributor to neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS)[^4]. Axonal transport deficits resulting from microtubule dysfunction lead to accumulation of proteins and organelles, synaptic loss, and ultimately neuronal death.
Structure and Composition
Microtubules are hollow cylindrical polymers with a diameter of approximately 25 nm and a lumen diameter of approximately 15 nm:
Assembly and Architecture
-
Protofilaments: 13 linear chains of α/β-tubulin heterodimers form the microtubule wall in most eukaryotic cells[^5]
-
Polar structure: Microtubules have distinct plus (+) and minus (-) ends with different assembly properties—the plus end exhibits faster growth and shrinkage
-
GTP binding: β-Tubulin binds GTP, which is hydrolyzed to GDP after incorporation, stabilizing the lattice
-
Lattice structure: A- and B-lattice arrangements differ in their seam structure, affecting dynamic instability
Tubulin Isotypes
Multiple tubulin genes encode distinct isotypes with tissue-specific expression and functional specialization[^6]:
| Isotype | Genes | Tissue Distribution |
|---|---|---|
| α-Tubulin | TUBA1A, TUBA1B, TUBA3E, TUBA4A, TUBA8 | Ubiquitous, neuron-specific variants |
| β-Tubulin | TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB8 | Tissue-specific isoforms |
| γ-Tubulin | TUBG1, TUBG2 | Centrosome/MTOC |
| δ/ε-Tubulin | TUBD1, TUBD2 | Centrioles |
Dynamic Instability
Microtubules undergo constant assembly and disassembly through a process called dynamic instability[^7]:
| Phase | Description |
|---|---|
| Rescue | Transition from shrinkage to growth |
| Catastrophe | Transition from growth to shrinkage |
| Growth rate | ~1 μm/min under physiological conditions |
| Shrinkage rate | ~10-15 μm/min |
This dynamic behavior is regulated by:
-
Microtubule-associated proteins (MAPs): Tau, MAP2, and others stabilize or destabilize microtubules
-
Post-translational modifications: Acetylation, detyrosination, polyglutamylation affect motor protein binding
-
Tubulin GTPase activity: Essential for dynamic instability
-
Calcium and microtubule-stabilizing drugs: Can alter assembly dynamics
Role in Axonal Transport
Neurons rely on microtubules for long-distance transport of cargo between the cell body and synapses:
Molecular Motors
Two major motor protein families power axonal transport:
-
Kinesins: Primarily move cargo toward the plus end (anterograde transport from soma to synapse)
-
Dyneins: Move cargo toward the minus end (retrograde transport from synapse to soma)
Cargo Types
Essential cargo transported along microtubules includes:
-
Synaptic vesicles: Neurotransmitter-containing vesicles for synaptic transmission
-
Mitochondria: Energy production at synapses
-
Proteins: Newly synthesized proteins delivered to synapses
-
Lipid membranes: For synaptic membrane maintenance
-
Autophagosomes: For protein turnover and quality control
Transport Deficits in Neurodegeneration
Axonal transport dysfunction is an early feature of many neurodegenerative diseases[^8]:
-
Reduced transport velocity and frequency
-
Accumulation of cargo in swellings and spheroids
-
Mitochondrial dysfunction due to impaired energy delivery
-
Synaptic protein depletion at nerve terminals
Microtubule Dysfunction in Neurodegenerative Diseases
Alzheimer’s Disease
In Alzheimer’s disease (AD), microtubule dysfunction contributes to axonal transport deficits[^9]:
-
Tau pathology: Hyperphosphorylated tau dissociates from microtubules, destabilizing them and impairing transport[^10]
-
Reduced microtubule density: Loss of stable microtubule networks in affected neurons
-
Motor protein dysfunction: Kinesin and dynein impairment from tau pathology
-
Axonal swellings: Accumulation of organelles and proteins due to transport blockages
Parkinson’s Disease
Microtubule alterations in Parkinson’s disease (PD) include[^11]:
-
α-Synuclein interactions: Pathological α-synuclein can bind microtubules and disrupt transport
-
Dynein dysfunction: Impaired retrograde transport affects lysosomal function and protein clearance
-
Mitochondrial transport deficits: Reduced mitochondrial trafficking to synapses
Huntington’s Disease
In Huntington’s disease (HD), microtubule dysfunction results from[^12]:
-
Mutant huntingtin binding: Direct interaction with microtubule motors impairs transport
-
Reduced anterograde transport: Kinesin function specifically affected
-
BDNF transport deficits: Impaired delivery of neurotrophic factors to striatal neurons
Amyotrophic Lateral Sclerosis (ALS)
ALS features microtubule defects including[^13]:
-
Dynein mutations: Mutations in dynein heavy chain (DNAH5, DNAH17) linked to ALS
-
Microtubule destabilization: Loss of stable microtubule networks
-
Axonal transport deficits: Early and prominent transport impairment
Therapeutic Strategies
Microtubule-Stabilizing Agents
Drugs that stabilize microtubules show promise for neurodegenerative diseases[^14]:
-
Taxol (paclitaxel): Stabilizes microtubules but has limited CNS penetration
-
Epothilone D: Brain-penetrant microtubule stabilizer in clinical trials for AD[^15]
-
Davunetide (NAP): Microtubule-stabilizing peptide showing promise in preclinical models
Motor Protein Modulators
Targeting kinesin and dynein function:
-
Kinesin enhancers: Improving anterograde transport
-
Dynein modulators: Enhancing retrograde transport and clearance
Microtubule-Targeted Therapies in Development
| Drug/Compound | Mechanism | Development Stage |
|---|---|---|
| Epothilone D | Microtubule stabilization | Clinical trials (AD) |
| Davunetide | Peptide stabilizer | Preclinical |
| TPI-287 | Taxane derivative | Phase I/II (AD) |
| ABT-199 | Kinesin modulator | Preclinical |
Microtubule-Associated Proteins (MAPs)
MAPs regulate microtubule dynamics and serve as bridges to other cellular structures:
Tau Protein
Tau is the most studied MAP in neurodegeneration[^16]:
-
Binds to microtubules via repeat domains
-
Hyperphosphorylation in AD causes microtubule destabilization
-
Six tau isoforms expressed in adult human brain
-
Mutations in MAPT gene cause frontotemporal dementia
MAP2
Primarily expressed in dendrites, MAP2 stabilizes dendritic microtubules:
-
Three isoforms (MAP2A-D, MAP2B, MAP2C/D)
-
Phosphorylation regulates binding affinity
-
Dendrite-specific function differs from axonal tau
Other MAPs
-
MAP1A/1B: Ubiquitous MAPs with roles in neuronal development
-
MAP4: Mitotic MAP not typically expressed in mature neurons
See Also
External Links
Overview
Expand Microtubules Content plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Expand Microtubules Content has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
Brain Mapping Resources:
-
Allen Human Brain Atlas — Comprehensive human brain gene expression
-
Allen Mouse Brain Atlas — Mouse brain atlas
-
BrainSpan Atlas — Developing human brain transcriptome
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.